Shandong Kexing Bioproducts Co., Ltd.

Its R&D team consists of 10 specialists with strong experience in research institutes and hospitals. The team is good at drug development, clinical trials, and regulatory submission.

With expertise in molecular chemistry and biochemistry, the team focuses on therapeutic drugs targeting kidney diseases and tumors. Currently there are 3 novel products in its R&D pipeline. The team conducts in-depth preclinical and clinical studies to acquire the drug safety and efficacy data needed for SFDA drug application. The products are based on in-house R&D team and external collaboration.